ALTERITY THERAPEUTICS-ADR (ATHE) Stock Cash Flow
NASDAQ:ATHE - Nasdaq - US02155X2053 - ADR - Currency: USD
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 8.85M | 15.80K | 4.58M | 391.85K | 4.94M | |||
| Interest Paid | -7.22K | -4.57K | -2.29K | -1.30K | -3.88K | |||
| Taxes Paid | -58.02K | -103.45K | -43.08K | N/A | N/A | |||
| OPERATING CASH FLOW | -12.61M | -20.04M | -12.34M | -17.33M | -9.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.72K | -7.31K | -89.15K | -10.47K | -16.74K | |||
| Other Investing Activity | 0.00 | -29.15K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -5.72K | -36.46K | -89.15K | -10.47K | -16.74K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -10.37K | -59.92K | -34.51K | -58.29K | -89.24K | |||
| Stock Issued/Repurchased | 10.14M | 316.68K | 17.18M | 39.24M | 4.36M | |||
| Other Financing Activity | -918.02K | -132.41K | -836.97K | -2.49M | -292.77K | |||
| FINANCING CASH FLOW | 9.22M | 124.34K | 16.30M | 36.69M | 3.98M | |||
| Exchange Rate Effect | 260.36K | 914.94K | 2.81M | -426.78K | 262.98K | |||
| CHANGE IN CASH | -3.13M | -19.03M | 6.69M | 18.92M | -5.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -12.61M | -20.04M | -12.34M | -17.33M | -9.43M | |||
| Capital Expenditure | -5.72K | -7.31K | -89.15K | -10.47K | -16.74K | |||
| FREE CASH FLOW | -12.61M | -20.04M | -12.43M | -17.34M | -9.45M | |||
All data in AUD